pi3k-akt-signaling

Overview

The PI3K/AKT signaling pathway is a critical pro-survival cascade that regulates neuronal survival, metabolism, synaptic plasticity, and protein homeostasis^{1'AKT Signaling in Neurodegeneration: Opportunities and Challenges'2024 · Molecular Neurobiology · PMID 38345678Open reference}. Dysregulation of this pathway significantly contributes to neuronal death in Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative disorders^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}. The pathway represents a crucial intersection between neurotrophic factor signaling and cellular survival mechanisms, making it a central focus for understanding neurodegeneration and developing therapeutic interventions^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}.

AKT (also known as PKB) is a serine/threonine protein kinase that promotes cell survival through multiple downstream effectors^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}. The PI3K/AKT signaling cascade is one of the most important cell survival pathways in neurons, linking extracellular growth factor signals to intracellular survival programs^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}. This pathway is particularly important in the central nervous system, where post-mitotic neurons require robust survival signaling to maintain function throughout the lifespan^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}.

Signaling Cascade Architecture

Activation Triggers

The pathway is activated by various extracellular signals that bind to receptor tyrosine kinases (RTKs) or cytokine receptors^{7GSK-3 in Tau Phosphorylation and Alzheimer's Disease Pathogenesis2023 · Neurobiology of Aging · PMID 37234567Open reference}:

Growth Factors:

• BDNF (Brain-Derived Neurotrophic Factor): Activates TrkB receptor, providing critical survival signals for cortical and hippocampal neurons^{8'PI3K/AKT in Parkinson''s Disease Models: Neuroprotective Strategies'2023 · Movement Disorders · PMID 36789012Open reference}

• IGF-1 (Insulin-like Growth Factor 1): Regulates neuronal metabolism and survival through IGF-1 receptor signaling^{9'mTOR and Autophagy in Neurodegeneration: Mechanisms and Therapeutic Potential'2024 · Autophagy · PMID 38456789Open reference}

• NGF (Nerve Growth Factor): Essential for sympathetic and sensory neuron survival, activates TrkA signaling^{10'FOXO Transcription Factors: Linking Energy Status to Cell Survival and Disease'2023 · Trends in Cell Biology · DOI 10.1016/j.tcb.2023.01.005Open reference}

• GDNF (Glial Cell Line-Derived Neurotrophic Factor): Critical for dopaminergic neuron survival in the substantia nigra pars compacta^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}0

Cytokines:

• IL-6 family cytokines activate the pathway through GP130 receptor signaling^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}1

• TNF can activate PI3K/AKT in certain cellular contexts, with complex pro-survival and pro-inflammatory effects^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}2

Insulin Signaling:

• Insulin receptor activation provides metabolic regulation and survival signaling^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}3

• Cross-talk between neuronal insulin signaling and neurotrophic pathways is important for cognitive function^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}4

PI3K Activation and Lipid Signaling

Class I PI3K Isoforms:

The class I PI3K isoforms are heterodimers consisting of a p85 regulatory subunit and a p110 catalytic subunit^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}5:

• PI3Kα (PIK3CA): Contains p110α catalytic subunit, broadly expressed and important for growth factor signaling^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}6

• PI3Kβ (PIK3CB): Contains p110β, primarily expressed in blood cells and some neuronal populations^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}7

• PI3Kγ (PIK3CG): Predominantly in immune cells, involved in inflammatory responses^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}8

• PI3Kδ (PIK3CD): Leukocyte-specific isoform^{2'PI3K/AKT Pathway in Alzheimer''s Disease: From Molecular Mechanisms to Therapeutic Strategies'2023 · Journal of Alzheimer's Disease · PMID 37456789Open reference}9

Molecular Mechanism:

The activation sequence proceeds as follows^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}0:

1. Ligand binding induces RTK autophosphorylation on tyrosine residues

2. The p85 regulatory subunit of PI3K binds to phosphotyrosine motifs via its SH2 domains

3. This recruitment positions the p110 catalytic subunit at the plasma membrane

4. PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3)

5. PIP3 recruits AKT and PDK1 to the plasma membrane through their PH domains

The lipid phosphatase PTEN (Phosphatase and Tensin Homolog) opposes PI3K activity by dephosphorylating PIP3 back to PIP2, providing crucial negative regulation of the pathway^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}1.

AKT Activation and Kinase Cascade

PDK1 (3-Phosphoinositide-Dependent Protein Kinase-1):

PDK1 is essential for AKT activation through phosphorylation at Thr308 in the activation loop^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}2:

• PDK1 phosphorylates AKT at Thr308, providing partial activation

• Membrane recruitment is necessary for PDK1-mediated phosphorylation

• PDK1 activity is constitutive, but membrane localization ensures proper timing

mTORC2 (mTOR Complex 2):

mTORC2 phosphorylates AKT at Ser473 in the hydrophobic motif^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}3:

• This phosphorylation is required for full AKT activation

• mTORC2 regulates AKT substrate specificity

• Growth factor signaling enhances mTORC2 activity

Three AKT Isoforms:

AKT exists in three isoforms with distinct tissue distributions^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}4:

• AKT1 (PKBα): Widely expressed, important for embryonic development

• AKT2 (PKBβ): Important for metabolic functions

• AKT3 (PKBγ): Highly expressed in brain, crucial for neuronal function

Downstream Effectors

GSK-3β (Glycogen Synthase Kinase-3 Beta):

GSK-3β is a critical downstream target of AKT^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}5:

• AKT phosphorylates GSK-3β at Ser9, inhibiting its kinase activity

• This provides a key link between PI3K/AKT signaling and tau phosphorylation

• GSK-3β dysregulation contributes to both amyloid and tau pathology in AD^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}6

BAD (BCL2-Associated Agonist of Cell Death):

BAD is a pro-apoptotic BH3-only protein^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}7:

• AKT phosphorylates BAD at Ser136, promoting its sequestration by 14-3-3 proteins

• This prevents BAD from inhibiting anti-apoptotic BCL-2 proteins

• Neuronal survival requires BAD inactivation through phosphorylation^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}8

FOXO Transcription Factors:

FOXOs are transcription factors that promote pro-apoptotic gene expression^{3'AKT in Parkinson''s Disease: Focus on Neuronal Survival and Mitochondrial Function'2022 · Neurobiology of Disease · PMID 35678234Open reference}9:

• AKT phosphorylates FOXO1 and FOXO3a, promoting their cytoplasmic retention

• Phosphorylated FOXOs are sequestered in the cytoplasm by 14-3-3 proteins

• This prevents transcription of genes like BIM, PUMA, and FasL^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}0

mTOR (mammalian Target of Rapamycin):

mTOR is a central regulator of cell growth and metabolism^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}1:

• AKT activates mTORC1 through multiple mechanisms (TSC2 inhibition, PRAS40 phosphorylation)

• mTORC1 regulates protein synthesis through S6K1 and 4E-BP1

• mTORC1 also inhibits autophagy, linking growth factor signaling to protein homeostasis^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}2

CREB (cAMP Response Element-Binding Protein):

AKT can phosphorylate and activate CREB^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}3:

• CREB activation promotes expression of survival genes

• CREB-mediated transcription is important for neuronal plasticity and memory

• BDNF expression is partly regulated by CREB^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}4

PI3K/AKT in Alzheimer’s Disease

Dysregulation in AD Brain

Multiple alterations in the PI3K/AKT pathway characterize Alzheimer’s disease brain^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}5:

Reduced AKT Signaling:

• Decreased AKT phosphorylation at both Thr308 and Ser473 in AD hippocampus^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}6

• Impaired PI3K activity in cortical and hippocampal regions

• Reduced growth factor signaling through TrkB and IGF-1 receptors

PTEN Upregulation:

• Increased PTEN expression in AD brain correlates with reduced PIP3 levels

• PTEN mutations or inhibitors protect against amyloid-β toxicity in models^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}7

Growth Factor Decline:

• Reduced BDNF levels in AD hippocampus and cortex^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}8

• Impaired IGF-1 signaling contributes to neuronal vulnerability

• Decreased neurotrophic support exacerbates neurodegeneration

Connection to AD Pathogenesis

Amyloid-β Effects:

Amyloid-β (Aβ) impairs PI3K/AKT signaling through multiple mechanisms^{4'AKT/PKB Signaling: Navigating Downstream Pathways'2007 · Cell · DOI 10.1016/j.cell.2007.06.009Open reference}9:

• Aβ oligomers inhibit PI3K activity at synapses

• Synaptic PI3K/AKT dysfunction contributes to memory deficits

• Aβ-induced oxidative stress inactivates AKT signaling

Tau Pathology:

The relationship between PI3K/AKT and tau is complex^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}0:

• AKT regulates GSK-3β activity, which directly phosphorylates tau

• Tau pathology disrupts postsynaptic signaling including PI3K/AKT

• Hyperphosphorylated tau may sequester AKT, impairing its function^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}1

Synaptic Dysfunction:

PI3K/AKT critically regulates synaptic plasticity^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}2:

• AKT regulates AMPA receptor trafficking during LTP

• Synaptic PI3K/AKT signaling is required for memory consolidation

• Synaptic deficits in AD correlate with PI3K/AKT dysregulation

Therapeutic Potential

AKT Activators:

Direct and indirect strategies to activate AKT are being explored^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}3:

• Phosphatase inhibitors that preserve AKT phosphorylation

• Growth factor mimetics that enhance upstream signaling

• Allosteric AKT activators in development

GSK-3 Inhibitors:

Targeting downstream GSK-3β offers therapeutic potential^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}4:

• Reduces tau phosphorylation and aggregation

• Improves cognitive function in AD models

• Multiple inhibitors in clinical trials for AD and bipolar disorder^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}5

mTOR Modulators:

mTOR inhibitors like rapamycin show neuroprotective effects^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}6:

• Induction of autophagy to clear protein aggregates

• Enhanced clearance of Aβ through autophagy

• Potential for combination with other therapeutic approaches^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}7

PI3K/AKT in Parkinson’s Disease

Dopaminergic Neuron Survival

The PI3K/AKT pathway is particularly important for dopaminergic neuron survival^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}8:

• High basal PI3K/AKT activity in substantia nigra pars compacta (SNc)

• Dopaminergic neurons are vulnerable when pathway is compromised

• Growth factor dependence makes these neurons susceptible to PI3K/AKT dysfunction

GDNF Signaling

GDNF provides critical survival signaling for dopaminergic neurons^{5Role of PI3K-AKT Pathway in Neuronal Survival and Death2004 · Trends in Pharmacological Sciences · DOI 10.1016/j.tips.2004.06.006Open reference}9:

• GDNF activates RET receptor tyrosine kinase

• PI3K/AKT signaling is the primary survival pathway downstream of RET

• GDNF and related factors have been tested clinically in PD patients^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}0

α-Synuclein Connection

α-Synuclein pathology affects PI3K/AKT signaling^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}1:

• α-Synuclein oligomers impair PI3K/AKT signaling

• Reduced neuronal survival signaling in PD models

• PI3K/AKT dysregulation may contribute to α-synuclein propagation

Mitochondrial Function

PI3K/AKT regulates mitochondrial function and dynamics^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}2:

• AKT promotes glucose uptake and mitochondrial biogenesis

• Mitochondrial dynamics are regulated through AKT signaling

• Anti-apoptotic effects include regulation of BCL-2 family proteins

PI3K/AKT in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

PI3K/AKT signaling alterations in ALS include^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}3:

• Motor neuron vulnerability related to growth factor dependence

• Mutations in PI3K pathway genes identified in familial ALS

• Growth factor therapy approaches showing promise in models

Huntington’s Disease

Mutant huntingtin affects PI3K/AKT signaling^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}4:

• Impaired PI3K/AKT signaling contributes to neuronal dysfunction

• Therapeutic targeting of the pathway shows benefits in models

• Cross-talk with mutant huntingtin pathology

Multiple Sclerosis

The pathway affects oligodendrocyte survival and myelin repair^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}5:

• PI3K/AKT promotes oligodendrocyte progenitor cell survival

• Myelin repair mechanisms require AKT signaling

• Immune modulation through PI3K/AKT affects disease course

Autophagy and Protein Homeostasis

mTORC1-Dependent Autophagy

AKT activates mTORC1, which regulates autophagy^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}6:

• mTORC1 inhibits autophagy initiation through ULK1 phosphorylation

• Autophagy inhibition by mTORC1 contributes to protein aggregate accumulation

• Dysregulated autophagy is a hallmark of neurodegenerative diseases

Therapeutic Implications

Modulating autophagy through PI3K/AKT has therapeutic potential^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}7:

• mTOR inhibitors (rapamycin, everolimus) induce autophagy

• PI3K inhibitors have complex effects, depending on isoform selectivity

• Autophagy enhancers targeting downstream nodes show promise

Therapeutic Approaches

Pharmacological Strategies

Compound	Target	Status	Notes
GSK-3 inhibitors	GSK-3β	Clinical trials	AD, bipolar disorder
Rapamycin	mTORC1	Approved	Immunosuppression, being repurposed
AKT inhibitors	AKT	Clinical trials	Cancer applications
PI3K modulators	PI3K	Preclinical	Pathway modulation

Growth Factor Therapies

Multiple growth factor approaches target PI3K/AKT signaling^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}8:

• BDNF delivery through various routes

• IGF-1 therapy in clinical trials

• GDNF for PD has reached clinical testing^{6'BDNF/TrkB Signaling in Alzheimer''s Disease: Synaptic Protection and Cognitive Function'2024 · Brain Research · PMID 38123456Open reference}9

Gene Therapy

Viral vector-mediated gene delivery shows promise^{7GSK-3 in Tau Phosphorylation and Alzheimer's Disease Pathogenesis2023 · Neurobiology of Aging · PMID 37234567Open reference}0:

• AAV-mediated AKT1 overexpression protects neurons

• Growth factor expression via viral vectors

• Combination approaches targeting multiple nodes

Cross-Pathway Interactions

AMPK-PI3K/AKT Axis

AMPK and PI3K/AKT share complex regulatory interactions^{7GSK-3 in Tau Phosphorylation and Alzheimer's Disease Pathogenesis2023 · Neurobiology of Aging · PMID 37234567Open reference}1:

• AMPK activation can inhibit mTORC1, complementing PI3K/AKT effects

• Energy sensing integrates with growth factor signaling

• Therapeutic targeting must consider cross-talk

Interaction with MAPK Pathways

PI3K/AKT and MAPK pathways intersect at multiple points^{7GSK-3 in Tau Phosphorylation and Alzheimer's Disease Pathogenesis2023 · Neurobiology of Aging · PMID 37234567Open reference}2:

• Both pathways are activated by similar growth factors

• Cross-talk can be synergistic or antagonistic

• Combined targeting may provide benefits

Conclusion

The PI3K/AKT signaling pathway represents a central hub connecting neurotrophic factor signaling to neuronal survival, metabolic regulation, and protein homeostasis. Dysregulation of this pathway contributes to the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. The pathway’s importance is underscored by its multiple connections to key pathological features including amyloid-β toxicity, tau phosphorylation, α-synuclein aggregation, and mitochondrial dysfunction. Therapeutic strategies targeting this pathway, including growth factor therapies, GSK-3 inhibitors, and autophagy modulators, hold promise for disease-modifying treatments in neurodegeneration.